Showing results (361-370 of 401) with videos related to
Sort By:
Pageof 41
Supportive Cancer Therapy|July 18, 2008
Palmar-plantar erythrodysesthesia in patients receiving capecitabine and intratumor thymidine phosphorylase and dihydropyrimidine dehydrogenase: is there a pharmacologic explanation?Muhammad Wasif Saif, Vinni Juneja, Glenda Black, et al.Cancer Chemotherapy and Pharmacology|March 9, 2007
A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumorsMuhammad Wasif Saif, Sandra Sellers, Mao Li, et al.Cutaneous and Ocular Toxicology|June 12, 2009
Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancerWaris Waris, Seeta Naik, Imran Idrees, et al.Eurasian Journal of Medicine and Oncology|February 28, 2020
Ethnic Differences in Hematologic Toxicity from Imatinib in Patients with Gastrointestinal Stromal Cell Tumor (GIST): Coincidence or a Real PhenomenonMuhammad Wasif Saif, Sneha Purvey, Kristin Kaley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with CaucasiansLori Kay Mattison, Jeanne Fourie, Renee A Desmond, et al.Case Reports in Medicine|September 24, 2010
Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal PancreatectomyMuhammad Wasif Saif, Natalie Galanina, L Ravage-Mass, et al.Journal of Cellular Signaling|July 1, 2020
Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI MalignanciesAmandeep Godara, Nauman S Siddiqui, Hilal Hachem, et al.Journal of Cellular Signaling|July 2, 2020
COVID-19 Clinical ResearchJeffrey Chi, David Chitty, Meeyoung Lee, et al.Cancer Chemotherapy and Pharmacology|April 23, 2016
Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasmaJia Li, Harriet Kluger, Lesley Devine, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 23, 2010
Nutritional status of patients with locally advanced pancreatic cancer: a pilot studyLeah M Ferrucci, Diana Bell, Jennifer Thornton, et al.Pageof 41